Climate Change Data

Environmental Metrics

ESG Focus Areas

• Quality and Innovation
• Responsible Operation
• Talent Care and Management
• Environmental Protection
• Community Contribution

Environmental Achievements

• No violations related to air and greenhouse gas emissions, discharges into water and land, and generation of hazardous and non-hazardous waste.
• Adopted emissions reduction measures on vehicles and electricity saving.

Social Achievements

• No work-related injuries and fatalities during the Reporting Period.
• No cases of violation in hiring child labour or forced labour.
• Introduced performance bonus policy.
• Provided annual health checks and comprehensive medical examinations for employees.
• Issued a COVID-19 One-off Special Care Allowance.

Governance Achievements

• Established an Anti-fraud, Anti-money Laundering, and Anti-bribery Management System.
• Organized an Anti-corruption and Compliance Training for employees.
• The Group was not involved in any litigations of corruption or bribery.
• Formulated the Packaging Component Artwork Design and Approval Management Procedure for Local Manufacture and Repackaging Product and the Packaging Component Artwork Design and Approval Management Procedure for Imported Product.

Climate Goals & Targets

Environmental Challenges

• Minimizing environmental impact from daily office work and laboratory operations (electricity, water, waste).

Mitigation Strategies

• Formulated the Environmental Protection System to strengthen environmental protection and minimize pollutions and influences due to drug production.
• Implemented various measures for exhaust and GHG emissions management, waste management, and paper management.
• Implemented energy and water saving measures.

Supply Chain Management

Supplier Audits: 300 suppliers

Responsible Procurement

• Strict review of new suppliers (qualification check, compliance check, on-site visit)
• Selection criteria include business ethics, environmental, health and safety

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited

Environmental Metrics

ESG Focus Areas

• Compliant operations
• Business ethics
• Quality control and safety of products
• Technology development and product innovation
• Intellectual property protection
• Privacy and data protection
• Safety of and communication with clinical trial participants
• Employees’ health and safety
• Emissions control (including exhaust emissions, greenhouse gases emissions and wastewater discharge)
• Waste disposal and management
• International strategic cooperation
• Improving corporate governance
• Responsible procurement and supply chain management
• Training and development of employees
• Employee welfare
• Employee rights/Labour standards
• Employee diversity and equal opportunities
• Water consumption and efficiency
• Energy consumption and efficiency
• Mitigation and adaptation of climate change
• Community charity

Environmental Achievements

• HKD 5 Million Green Deposit for Funding Green Projects

Social Achievements

• No work-related fatalities
• No child labor or forced labor
• Organized various training programs for employees (Orientation Training, Commercialization Team Direct Manager (DM) Training Program, Project Management Training, Online Excel Application Course)
• Implemented flexible work-from-home options during the COVID-19 pandemic
• Distributed gift packages to employees and their families in need during lockdown periods

Governance Achievements

• Formalized an Anti-Bribery and Corruption Prevention Policy
• Established a Whistle Blowing Policy
• Established the ERP systems and applications to digitalize the segregation of duties, authorizations and review and approval flows

Climate Goals & Targets

Environmental Challenges

• Launch of XPOVIO® (selinexor, ATG-010) in mainland China was delayed because of government covid-zero policy measures in the second quarter of 2022
• Travel and hospital restrictions and regional covid-zero policy across major cities in the second half of 2022 and the major shift in China’s COVID-19 policy in December 2022 has impacted our commercialization negatively

Mitigation Strategies

• Implemented flexible work-from-home options for employees
• Distributed gift packages to employees and their families in need during lockdown periods
• Managed to launch XPOVIO® even during the height of the Shanghai covid-zero policy in mid-May

Supply Chain Management

Supplier Audits: 877 suppliers

Responsible Procurement

• Require suppliers to sign a letter of commitment to ensure that they comply with the requirements of social corporate responsibility and environmental protection

Climate-Related Risks & Opportunities

Physical Risks

• Typhoon
• Flood
• Extreme heat

Transition Risks

• Regulatory changes

Awards & Recognition

• 2021 Top 100 Biotech Companies in China
• The Most Valuable Biopharmaceutical Company Award
• The Best Listed Companies in New Economy
• Top 20 Most Influential Antibody Companies
• Top 20 Most Influential Antibody Companies
• Excellence in Corporate Social Responsibility in Healthcare and Biotech
• 2022 Responsible Brand Award and Corporate Social Responsibility Award
• CR Guardian Award
• Nominee for the “Best Biotechnology Products ” Award